Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TET3 | O43151 | 1/20 | 0.33 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.33 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19912994 | 0.75 | SMN1; SMN2 (0.31) | SMN1; SMN2 | |
| SCHEMBL8416906 | 0.74 | SMN1; SMN2 (0.60) | TET2SMN1; SMN2TET3TET1SLC22A6 | |
| SCHEMBL125700 | 0.74 | SMN1; SMN2 (0.60) | TET2SMN1; SMN2TET3TET1SLC22A6 | |
| SCHEMBL8417005 | 0.74 | SMN1; SMN2 (0.60) | TET2SMN1; SMN2TET3TET1SLC22A6 | |
| SCHEMBL19912991 | 0.71 | CYP2C9 (0.33) | — | |
| SCHEMBL19912995 | 0.68 | OR51E2 (0.36) | TET2SMN1; SMN2TET3TET1SLC22A6 | |
| SCHEMBL28292844 | 0.67 | — | — | |
| SCHEMBL13828456 | 0.67 | — | — | |
| Acetaldehyde SCHEMBL18398677 | 0.67 | GAPDH (0.33) | — | |
| SCHEMBL7063820 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180057897-A1 | Synthesis of Furans from Sugars Via Keto Intermediates | BP CORPORATION NORTH AMERICA INC. (US) | 2018-03-01 | — | — | US | disclosed |
| EP-3265450-A1 | SYNTHESIS OF FURANS FROM SUGARS VIA KETO INTERMEDIATES | BP Corporation North America Inc. (US) | 2018-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180057897-A1 | Synthesis of Furans from Sugars Via Keto Intermediates | KHK, HPD, ALDOA | TET2 611/4885SMN1; SMN2 4421/4885TET3 337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.